The estimated Net Worth of Crystal Muilenburg is at least $2.17 Milión dollars as of 8 March 2022. Ms Muilenburg owns over 6,495 units of Evolus Inc stock worth over $2,049,967 and over the last 4 years she sold EOLS stock worth over $123,144.
Sign up
Ms Muilenburg EOLS stock SEC Form 4 insiders trading
Ms has made over 2 trades of the Evolus Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently she sold 6,495 units of EOLS stock worth $63,196 on 8 March 2022.
The largest trade she's ever made was selling 6,495 units of Evolus Inc stock on 8 March 2022 worth over $63,196. On average, Ms trades about 2,964 units every 53 days since 2021. As of 8 March 2022 she still owns at least 134,248 units of Evolus Inc stock.
You can see the complete history of Ms Muilenburg stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ms. Crystal Muilenburg biography
Crystal Muilenburg is the Chief Marketing Officer at Evolus Inc.
How old is Ms Muilenburg?
Ms Muilenburg is 41, she's been the Chief Marketing Officer of Evolus Inc since . There are 11 older and 1 younger executives at Evolus Inc. The oldest executive at Evolus Inc is Peter Farrell, 78, who is the Independent Director.
What's Ms Muilenburg's mailing address?
Crystal's mailing address filed with the SEC is 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660.
Insiders trading at Evolus Inc
Over the last 7 years, insiders at Evolus Inc have traded over $244,915,132 worth of Evolus Inc stock and bought 3,308,677 units worth $53,545,237 . The most active insiders traders include Biopharma, Inc. Aeon, Inc. Medytox a 1 Llc Alphaeon. On average, Evolus Inc executives and independent directors trade stock every 25 days with the average trade being worth of $3,606,270. The most recent stock trade was executed by Sandra Beaver on 6 September 2024, trading 3,276 units of EOLS stock currently worth $49,074.
What does Evolus Inc do?
evolus, inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the united states. it offers jeuveau, a proprietary 900 kilodalton purified botulinum toxin type a formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. the company was founded in 2012 and is headquartered in newport beach, california.
What does Evolus Inc's logo look like?
Complete history of Ms Muilenburg stock trades at Evolus Inc
Evolus Inc executives and stock owners
Evolus Inc executives and other stock owners filed with the SEC include:
-
Michael Jafar,
Chief Commercial Officer -
David Moatazedi,
President, Chief Executive Officer, Director -
Rui Avelar,
Chief Medical Officer, Head of Research & Development -
David Moatazedi,
Pres, CEO & Director -
Lauren Silvernail,
Chief Financial Officer, Executive Vice President - Corporate Development -
Lauren P. Silvernail,
CFO & Exec. VP of Corp. Devel. -
Dr. Rui Avelar Dip.SportMed, M.D., C.CFP,
Chief Medical Officer and Head of R&D -
Karah Parschauer,
Independent Director -
Peter Farrell,
Independent Director -
Vikram Malik,
Chairman of the Board -
David Gill,
Independent Director -
Robert Hayman,
Independent Director -
Simone Blank,
Director -
Tram Bui,
IR Contact Officer -
Jeff Plumer,
General Counsel -
Jessica Novak,
Sr. VP of HR -
Crystal Muilenburg,
Chief Marketing Officer -
Kurt Knab,
VP of Sales -
Jeffrey J. Plumer,
Gen. Counsel -
David K. Erickson,
VP of Investor Relations -
Biopharma, Inc. Aeon,
-
Sandra Beaver,
Chief Financial Officer -
Crystal Muilenburg,
Chief Marketing Officer -
Albert G Iii White,
Director -
Kristine Romine,
Director -
Bosun Hau,
Director -
1 Llc Alphaeon,
-
Brady Stewart,
Director -
Tomoko Yamagishi Dressler,
Chief Marketing Officer -
Inc. Medytox,